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Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) is a focal epilepsy with
attacks typically arising in the frontal lobe during non-rapid eye movement (NREM)
sleep. It is characterized by clusters of complex and stereotyped hypermotor seizures,
frequently accompanied by sudden arousals. Cognitive and psychiatric symptoms may be
also observed. Approximately 12% of the ADNFLE families carry mutations on genes
coding for subunits of the heteromeric neuronal nicotinic receptors (nAChRs). This is
consistent with the widespread expression of these receptors, particularly the α4β2∗
subtype, in the neocortex and thalamus. However, understanding how mutant nAChRs
lead to partial frontal epilepsy is far from being straightforward because of the complexity
of the cholinergic regulation in both developing and mature brains. The relation with
the sleep-waking cycle must be also explained. We discuss some possible pathogenetic
mechanisms in the light of recent advances about the nAChR role in prefrontal regions as
well as the studies carried out in murine models of ADNFLE. Functional evidence points to
alterations in prefrontal GABA release, and the synaptic unbalance probably arises during
the cortical circuit maturation. Although most of the available functional evidence concerns
mutations on nAChR subunit genes, other genes have been recently implicated in the
disease, such as KCNT1 (coding for a Na+-dependent K+ channel), DEPD5 (Disheveled,
Egl-10 and Pleckstrin Domain-containing protein 5), and CRH (Corticotropin-Releasing
Hormone). Overall, the uncertainties about both the etiology and the pathogenesis of
ADNFLE point to the current gaps in our knowledge the regulation of neuronal networks
in the cerebral cortex.
Keywords: ADNFLE, CHRNA2, CHRNA4, CHRNB2, GABA, nAChR, prefrontal cortex, sleep-related epilepsy
INTRODUCTION
Sleep has been long known to facilitate the occurrence of epileptic
seizures, particularly during non-rapid eye movement (NREM)
sleep (Boursoulian et al., 2013). Among themost common epilep-
tic syndromes associated with NREM sleep, we recall Idiopathic
Generalized Epilepsy (IGE, comprising a heterogeneous groups
of epilepsies), Idiopathic Focal Childhood Epilepsies (IFCE), the
Lennox-Gastaut Syndrome (LGS) and Temporolimbic Network
Epilepsy (TLNE). Another major epileptic syndrome related to
NREM sleep is nocturnal frontal lobe epilepsy (NFLE), whose
features were originally defined during the detailed characteri-
zation of cohorts of patients affected by paroxysmal nocturnal
dystonia (Provini et al., 1999; Tinuper and Lugaresi, 2002). The
familial form of NFLE has autosomal dominant inheritance and
was named ADNFLE (Scheffer et al., 1995). Because similar clin-
ical and electroencephalographic (EEG) features are displayed by
ADNFLE and the sporadic non-lesional cases of NFLE, ADNFLE
is a goodmodel of NFLE in general (Picard and Brodtkorb, 2008).
ADNFLE is a partial epilepsy often arising in childhood or
early adolescence. Attacks arise in the frontal lobe, usually dur-
ing stage 2 of sleep, and are characterized by clusters of complex
and stereotyped hyperkinetic seizures. This suggests that motor
patterns controlled by subcortical structures are released during
the attacks. Sudden arousals are also frequent in ADNFLE, which
is an indication of increased sleep fragmentation (Scheffer et al.,
1995; Picard and Brodtkorb, 2008). Cognitive deficit and psychi-
atric comorbidities can also be present and are probably more
common than initially assumed (Bertrand et al., 2005; Picard
et al., 2009). As in many other epilepsies, about one third of
the patients is refractory to pharmacological treatment. To date,
hundreds of ADNFLE families have been identified. Nonetheless,
because the genetic analysis is incomplete and because misdiag-
nosis is still frequent (Nobili et al., 2014), the exact incidence of
the disease is unknown. Ten to fifteen percent of the ADNFLE
families bear mutations on genes coding for subunits of the
neuronal nicotinic receptor (Di Corcia et al., 2005; Picard and
Brodtkorb, 2008; Ferini-Strambi et al., 2012; nAChR). The iden-
tification of other genes linked to ADNFLE has proceeded slowly.
Recently, ADNFLE mutations have been detected in KCNT1,
which codes for a Na+-gated K+ channel (Heron et al., 2012),
and DEPD5, coding for the Disheveled, Egl-10 and Pleckstrin
Domain-containing protein 5 (Ishida et al., 2013). Evidence is also
available about the implication of the corticotropin-releasing hor-
mone gene (CRH; Combi et al., 2005). Because little functional
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evidence is yet available for these genes, we here mostly focus on
how mutant nAChRs may cause ADNFLE.
The nAChR is a pentameric ion channel permeable to cations,
including Ca2+ (Fucile, 2004). When opened by ACh, it leads
to membrane depolarization, which can produce post-synaptic
excitation or, in presynaptic terminals, stimulation of neurotrans-
mitter release. In the mammalian brain, nine subunits concur in
forming functional nAChRs: α2-α7 and β2-β4, encoded respec-
tively by the CHRNA2-CHRNA7 and CHRNB2-CHRNB4 genes.
The two most common isoforms in thalamus and isocortex are
the heteropentamer α4β2∗ and the homopentamer (α7)5 (Dani
and Bertrand, 2007). The first ADNFLE mutation was identi-
fied in CHRNA4 (Steinlein et al., 1995). To date, four mutations
are known in CHRNA4 and six in CHRNB2 (Table 1), consistent
with the major role of α4β2∗ nAChRs in regulating neocortical
excitability (Wallace and Bertrand, 2013). The penetrance ranges
from 60 to 80%. Some mutations are more frequently associated
with psychiatric symptoms, but a specific relation between these
symptoms and the functional alterations produced by the mutant
subunits is not apparent (Steinlein et al., 2012). Finally, CHRNA2
(Table 1) has also been causally associated with ADNFLE (Aridon
et al., 2006). The α2 subunit can form heteromeric receptors by
associating with both β2 and β4 (e.g., Hoda et al., 2009; Di Resta
et al., 2010).
Besides the pathological relevance, the study of ADNFLE may
offer important insight into the function of nAChRs in the
cerebral cortex. In the present review, after summarizing some
relevant morphofunctional features of the frontal lobe and its
cholinergic innervation, we briefly discuss the sleep stages and
their relation with ADNFLE and nAChRs. Next, we review the
functional studies carried out with mutant nAChRs expressed in
cellular systems or animal models. These studies are interpreted
in the light of recent evidence about the physiological role of het-
eromeric nAChRs in different neocortical regions, in mature as
well as developing brains. We next discuss the possibility of tar-
geting the cholinergic system to treat ADNFLE. Finally, we briefly
analyze the other genes that have been implicated in ADNFLE, as
a perspective for future studies.
Table 1 | Mutations in ion channel-coding genes linked to ADNFLE.
Gene Protein/subunit Mutation Reference
CHRNA4 nAChR (α4) S248F Steinlein et al., 1995
S252L Hirose et al., 1999
776ins3 Steinlein et al., 1997
T265I Leniger et al., 2003
CHRNB2 nAChR (β2) V287L De Fusco et al., 2000
V287M Phillips et al., 2001
I312M Bertrand et al., 2005
L301V Hoda et al., 2008
V308A
CHRNA2 nAChR (α2) I279N Aridon et al., 2006




THE FRONTAL LOBES AND THE CHOLINERGIC SYSTEM
In primates, the frontal lobes can be broadly divided into three
functional regions: a caudal motor/premotor, a paralimbic (com-
prising the anterior cingulate complex, the parolfactory gyrus
and the posterior orbitofrontal regions), and an extensive rostral
heteromodal association area. The expression prefrontal cortex
(PFC) is generally reserved to the latter two sections, which are
extensively interconnected (Mesulam, 2000). The heteromodal
PFC is also connected with the unimodal and heteromodal associ-
ation cortices, while the paralimbic areas are directly linked to the
limbic system. In this way, the emotional and visceral states are
integrated with the sensory perception of external environment.
The PFC is crucially implicated in cognitive tasks, and particu-
larly in working memory, attention and goal-directed behavior.
Extensive connections also exist between PFC and subcorti-
cal structures such as the basal nuclei (particularly the caudate
nucleus) and the mediodorsal thalamus. PFC damage generally
decreases the flexibility of behavior (Shallice and Burgess, 1991;
Aron et al., 2004) and the capability of controlling impulse-driven
responses (Mesulam, 2000). Importantly for the present perspec-
tive, prefrontal lesions in rodents produce similar alterations of
executive functions (Dembrow and Johnston, 2014). Therefore,
rodents seem to constitute a reasonable model to study several
aspects of the frontal lobe physiology. For consistency with lit-
erature, we retain the expression PFC in rodents, although we
are aware of the difficulties of carrying out comparisons with the
much larger and complex dorsolateral PFC of primates (Uylings
et al., 2003).
The frontal functions are regulated by ascending projec-
tions from hypothalamic and brain stem nuclei, which control
the behavioral state and the sleep-waking cycle (Steriade and
McCarley, 2005). In particular, the cerebral cholinergic system is
composed of distinct groups of cholinergic neurons located in the
pons and basal forebrain. These project diffusely to the brain, but
especially to the cerebral cortex and thalamus (Mesulam, 2004).
ACh cooperates with noradrenaline, histamine and serotonin to
stimulate the neocortical tone, thus regulating arousal, attention
and goal-directed behavior (Lucas-Meunier et al., 2003; Sarter
et al., 2006; Wallace and Bertrand, 2013), as well as the switch
between sleep stages (Saper et al., 2010). Work carried out in
rodents indicates that the ascending cholinergic fibers densely
innervate the somatosensory, visual, motor and prefrontal cor-
tices, with a broadly homogeneous laminar distribution, espe-
cially in PFC (Eckenstein et al., 1988; Avendaño et al., 1996;
Mechawar et al., 2000; Henny and Jones, 2008; Aracri et al.,
2010).
The mechanisms by which ACh exerts its physiological func-
tions are very complex. First, ACh can activate both ionotropic
nAChRs and metabotropic (muscarinic) mAChRs. Early work
tended to highlight the contribution of mAChRs, and the
observed depolarizing effect of ACh on thalamic and neo-
cortical neurons during wakefulness and REM sleep was ini-
tially attributed to a mAChR-dependent K+ channel inhibi-
tion (Krnjevic´ et al., 1971; McCormick, 1992). More recently,
the prominent role of nAChRs in regulating brain excitability
and cognitive functions has been recognized (Picciotto et al.,
1995, 1998; Hahn et al., 2003; Bailey et al., 2010; Howe et al.,
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2010; Guillem et al., 2011). However, the distinct roles of the
numerous nAChR subunits expressed in the neocortex is poorly
understood (Gotti et al., 2007; Pistillo et al., 2015). Second,
although the overall effect of ACh in the neocortex is stimu-
latory, recent results indicate that the cholinergic terminals are
often adjacent to the soma and dendrites of GABAergic interneu-
rons, suggesting a strict relationship between the cholinergic and
the GABAergic systems (Henny and Jones, 2008; Aracri et al.,
2010). Therefore, alterations in cholinergic transmission may
have subtle effects on the balance between excitation and inhi-
bition in PFC circuits. Finally, several lines of evidence suggest
that non-synaptic (paracrine) ACh release is widespread in the
mammalian frontal cortex, but the balance of synaptic and non-
synaptic effects of ACh is still matter of debate (Umbriaco et al.,
1994; Mrzijak et al., 1995; Turrini et al., 2001; Descarries et al.,
2004; Lendvai and Vizi, 2008; Aracri et al., 2010; Sarter et al.,
2014).
THE STAGES OF SLEEP AND THEIR RELATION WITH
CHOLINERGIC TRANSMISSION AND EPILEPSY
Human sleep can be divided into several stages (Siegel, 2002;
Steriade andMcCarley, 2005). During attentive wakefulness, EEG
mostly comprises low voltage (5–10μV), high-frequency (20–
40Hz) beta waves. Ampler alpha oscillations at approximately
10Hz appear on relaxed waking. On falling asleep, these are sub-
stituted by mixed EEG rhythms, with frequency band similar to
the beta’s but higher amplitude (stage 1 sleep). This brief phase is
followed by stage 2 sleep, in which the EEG displays K-complexes
and sleep spindles, superimposed to the beta waves. The former
are sharp, high voltage transient waves that may occur sponta-
neously or be triggered by sensory stimuli. The sleep spindles are
wave discharges of 7–14Hz, lasting 1–2 s, and recurring at 0.1–
0.3Hz with a waxing and waning pattern (Lüthi, 2014). During
stage 3 and stage 4, the EEG becomes progressively dominated
by delta waves, with amplitudes up to 300μV and a frequency
of 0.5–3Hz. These stages are collectively named slow wave sleep
(SWS). Stage 1 to stage 4 constitute the NREM sleep, as indicated
by electro-oculogram. From stage 4, the sleeper reverts to stage 3
and stage 2, from which the rapid eye movement (REM) state can
be reached. In REM sleep, the EEG resembles the one observed
during wakefulness, but the subject is unconscious and the skele-
tal muscle tone is minimum. The most vivid oneiric activity takes
place in this stage. Sleep in non-human mammals is often simply
described in terms of SWS and REM sleep, with durations shorter
than in humans.
ACh release is high in wakefulness, strongly decreases dur-
ing NREM sleep, and rises again in REM sleep (Jones, 2008).
Many evidences point to the nicotinic receptors as important
mediators of these effects. More specifically, studies with mice
in which specific nAChR subunits were deleted show that the
β2∗ nAChRs mediate most of the arousing effects of nicotine
and regulate the NREM sleep stability. The transient activity
of β2∗ nAChRs, caused by the low-level ACh release during
NREM sleep, can stimulate “micro-arousal” events, at least in
mice (Léna et al., 2004). In ADNFLE, this phenomenon could
be potentiated by hyperfunctional α4β2 nAChRs, thus causing
the typical hyperexcitability with sudden arousals during NREM
sleep. Such interpretation would also point to a strong impli-
cation of local neocortical cholinergic mechanisms in ADNFLE,
which could explain an interesting neurophysiological difference
between NFLE and most of the other sleep-related epilepsies
(i.e., IGE, IFCE, LGS, and TLNE). In fact, the latter syndromes
are characterized by EEG spike-wave discharges (Halász, 2013).
These are thought to be caused by the interplay of cortical
and thalamic cells. The “spike” reflects the strong activation of
pyramidal cells, which is followed by the slower “wave” caused
by the inhibition produced on these cells by the activation of
local GABAergic interneurons as well as reticulothalamic (RT)
cells. Spike-wave activity is facilitated during NREM sleep by
the lower excitatory drive from the brain stem, which induces
neuronal synchrony in the thalamocortical network (Amzica
and Steriade, 2002; Halász, 2013). In contrast, in NFLE patients
the spike-wave seizures are much less frequent (Halász, 2013),
which points to an epileptogenic mechanisms characterized by
a stronger implication of local neocortical circuits. This would
be also in agreement with recent studies showing that cortical
arousal is particularly sensitive to the excitatory input provided
by the afferent fibers relayed through the basal forebrain, as com-
pared to the thalamic afferents (Fuller et al., 2011 and references
therein).
THE ADNFLE MUTANT nAChRs STUDIED IN EXPRESSION
SYSTEMS
Most of the functional studies carried out to date concern the
α4β2 subtype, to which the mutant ADNFLE subunits confer a
variety of functional alterations, whose physiological interpreta-
tion has given rise to controversy (Becchetti, 2012). Part of this
diversity probably derives from the usage of different expres-
sion systems (Xenopus oocytes or mammalian cell lines), and of
human or rodent nAChR subunit clones. Nonetheless, in the sim-
ulated heterozygous condition, which is the most relevant for rare
and dominant mutations, a gain of receptor function is com-
monly observed. This is often caused by increased sensitivity to
the agonists, accompanied or not by altered current kinetics (De
Fusco et al., 2000; Phillips et al., 2001; Itier and Bertrand, 2002;
Hoda et al., 2008). A similar increase was observed in the first
mutation identified in the α2 subunit (Aridon et al., 2006; Hoda
et al., 2009). One possible explanation of such an effect is that
ADNFLE subunits modify the nAChR subunit ratio (Son et al.,
2009). The α4β2 receptor can exist in at least two stoichiomet-
ric forms: (α4)3(β2)2 and (α4)2(β2)3. In heterologous expression
systems, the former prevails and presents an EC50 for ACh of
approximately 70μM, whereas the latter subtype accounts for
about 20% of the expressed receptors and presents an EC50 of
around 1μM (Nelson et al., 2003). In fact, five ADNFLE subunits
(α4-S248F, α4-S252L, α4-776ins3, β2-V287L, and β2-V287M)
were found to increase by 10–20% the proportion of the high-
affinity subtype, when expressed in mouse neuroblastoma cells
(Son et al., 2009). Another possible pathogenetic mechanism was
suggested based on the nAChR response to extracellular Ca2+
([Ca2+]o). The nAChRs are normally potentiated by increasing
[Ca2+]o up to the physiological concentration (Mulle et al., 1992;
Vernino et al., 1992). Higher [Ca2+]o produces channel inhibi-
tion (Buisson et al., 1996). The above five subunits, expressed
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in Xenopus oocytes, were observed to decrease the allosteric
potentiation caused by [Ca2+]o (Rodrigues-Pinguet et al., 2003).
This could affect presynaptic α4β2 receptors, leading to enhance
glutamate release during synchronous discharges of pyramidal
neurons (Rodrigues-Pinguet et al., 2003).
Regardless of the specific properties of individual mutations,
it remains to be explained why mutant subunits widely expressed
in the mammalian brain facilitate seizures in the frontal regions
during light NREM sleep and why the attacks are accompanied
by hyperkinetic motor events. Functional imaging studies show
that complex alterations of heteromeric nAChR expression take
place in human patients (Picard et al., 2006), which are difficult
to explain on the basis of the functional alterations observed in
cellular expression systems. Therefore, to better understand the
effects of ADNFLE mutations in the complex cerebral context,
it is necessary to proceed with broader studies of the cholinergic
transmission in animal models of ADNFLE.
MURINE MODELS OF ADNFLE
Since 2006, several murine models of ADNFLE have become
available. Klaassen et al. (2006) used C57BL/6J mice to generate
knock-in strains expressing either α4-S252F or α4-+L264, respec-
tively homologous to the human α4-S248F and α4-(776ins3).
Heterozygous mice present recurrent seizures accompanied by
increased nicotine-dependent GABA release in layer II/III of the
PFC (Klaassen et al., 2006) and layer V of the motor cortex
(Mann andMody, 2008). On the other hand, in a different genetic
background (CD1-129/Sv), expression of α4-S248F was found to
confer a nicotine-induced dystonic arousal complex similar to the
motor features of human ADNFLE, but no spontaneous seizures
(Teper et al., 2007).
The other mutant subunit that has been widely studied in
mice is β2-V287L. A knock-in strain expressing β2-V287L in
C57BL/6 background displays a disturbed sleep pattern, abnor-
mal excitability in response to nicotine, but no overt seizure
phenotype (Xu et al., 2011; O’Neill et al., 2013). Moreover, condi-
tional strains were generated expressing β2-V287L in FVB back-
ground, under control of the tetracycline promoter (TET-off sys-
tem;Manfredi et al., 2009). Expression of β2-V287L does not alter
the surface expression level of heteromeric nAChRs, but causes
spontaneous seizures, generally during periods of increased delta
wave activity. The epileptic phenotype is not reversed when β2-
V287L is silenced by administering doxycycline in adult mice.
Conversely, when the transgene is silenced between the embry-
onic day 1 and the postnatal day 15, no seizures are observed, even
if the transgene is expressed at a later stage.
Finally, in transgenic rats expressing α4-S284L, epileptic
seizures are observed during SWS. These are accompanied by
attenuation of synaptic and extrasynaptic GABAergic transmis-
sion before the onset of the epileptic phenotype and abnormal
glutamate release at the onset of seizures (Zhu et al., 2008).
In summary, these murine models of ADNFLE do not dis-
play gross morphological alteration in their brains, but tend
to display abnormal excitability, generally accompanied by dis-
turbed sleep. The presence of spontaneous seizures is strain-
dependent. The physiological analysis is incomplete, but points
to altered GABAergic transmission in PFC. Furthermore, the only
conditional model presently available suggests that critical stages
of synaptic stabilization are implicated in the pathogenesis of
ADNFLE.
NICOTINIC TRANSMISSION IN THE CEREBRAL CORTEX
nAChRs IN THE PFC
As was mentioned earlier, the heteropentamer α4β2∗ and the
homopentamer α75 are the main nAChR subtypes in thalamus
and isocortex (Gotti et al., 2007). Although the proportion of the
different stoichiometries of α4β2∗ receptors in vivo are unknown,
overall these receptors largely account for the highly sensitive and
slowly desensitizing component of the response to ACh and nico-
tine. Therefore, the heteromeric nAChRs are thought to give a
major contribution to the tonic control of neocortical excitabil-
ity even in the presence of low ACh concentrations. In contrast,
(α7)5 receptors have an EC50 for ACh of 100–200μM, much
faster desensitization and higher permeability to Ca2+ (Dani
and Bertrand, 2007), and seem thus to be better suited to reg-
ulate the phasic responses to high ACh concentrations. This
may explain why no ADNFLE mutation has ever been observed
in CHRNA7, despite the widespread expression of α7 subunits
in the brain.
The best characterized of the other subunits is α5, which can
associate with α4β2∗ receptors (Kuryatov et al., 2008) and regu-
late its function in both mature and developing PFC (Ramirez-
Latorre et al., 1996; Bailey et al., 2012). Unfortunately, nothing
is known about the interaction of α5 with the known ADNFLE
subunits. Very little is also known about the physiology of α2,
which is directly implicated in ADNFLE (Aridon et al., 2006).
The difficulty of interpreting the mutations on α2 resides in the
fact that its pattern of expression is different in primates as com-
pared to rodents. In particular, α2 is much more widely expressed
in primates’ brain (Han et al., 2000; Aridon et al., 2006), where
there seems to be much more overlap with α4 than in rodents’
brain. The other complication is that α2, as α4, can associate with
both β2 and β4 to yield functional nAChRs. The cerebral expres-
sion of β4 is also relatively widespread in mouse (Gahring et al.,
2004), squirrel monkeys (Quik et al., 2000) and human feti as well
as aged post-mortem samples (Hellström-Lindahl et al., 1998).
However, once again, scarce attention has been devoted to the
physiology of β4. Nevertheless, the above evidences suggest that
heteromeric receptors different from α4β2 could have important
physiological roles in the mammalian brain, and particularly in
primates.
nAChRs REGULATE BOTH EXCITATORY AND INHIBITORY
TRANSMISSION
In general, β2∗ nAChRs regulate glutamate release from thalam-
ocortical fibers (Vidal and Changeux, 1993; Gioanni et al., 1999;
Lambe et al., 2003). The expression and roles of nAChRs on pyra-
midal cell somata and terminals are more variable, depending on
species, layer and cerebral region (Chu et al., 2000; Couey et al.,
2007; Dickinson et al., 2008; Kassam et al., 2008; Zolles et al.,
2009; Marchi and Grilli, 2010; Poorthuis et al., 2012; Aracri et al.,
2013a). Nonetheless, the global effect of ACh release in deep lay-
ers is thought to be excitatory and dominated by β2∗ receptors
(Poorthuis et al., 2012). This is relevant in the present context,
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as layer V is particularly prone to develop seizures (Richardson
et al., 2008). During NREM sleep, the cholinergic tone is low,
but hyperfunctional nAChRs could maintain abnormal gluta-
mate release, even in the face of low ACh levels, thus increasing
sleep fragmentation. In fact, the rat strain expressing α4-S284L
shows higher nicotine-dependent glutamate release during SWS
(Zhu et al., 2008). It seems however unlikely that hyperfunctional
nAChRs can produce paroxystic hyperexcitability by a moderate
stimulation of glutamate release in the neocortex. Because the
pyramidal neuron activity is potently regulated by the feed-back
control exerted by GABAergic neurons, some degree of circuit
disinhibition is generally required to lead to seizure-like activ-
ity (Richardson et al., 2008). This is confirmed by theoretical
modeling showing that altering the “weight” of inhibitory con-
nections is the most effective way of modulating the excitability
of recurrent networks (Tsodyks et al., 1997; Murphy and Miller,
2009; Ozeki et al., 2009). Therefore, to understand the nAChR-
dependent hyperexcitability it is necessary to also consider the
nicotinic regulation of neocortical GABAergic transmission. In
fact, expression of heteromeric nAChRs on the soma of different
interneuronal populations is established in rats (Xiang et al., 1998;
Porter et al., 1999; Christophe et al., 2002), humans (Alkondon
et al., 2000) and mice (Couey et al., 2007; Aracri et al., 2010).
Heteromeric nAChRs also exert presynaptic control of GABA
release onto pyramidal cells (Klaassen et al., 2006; Aracri et al.,
2010).
THE ORIGIN OF SEIZURES IN ADNFLE
In the light of the above discussion, ADNFLE seizures could be
triggered by several mechanisms. (1) During SWS, thalamocorti-
cal neurons tend to be inhibited (Steriade and McCarley, 2005).
In these conditions, an upsurge of ACh in the presence of hyper-
functional nAChRs could cause excessive GABA release in the
PFC and thus abnormal hyperpolarization of pyramidal neu-
rons. This would deinactivate low-threshold, voltage-gated Ca2+
channels and activate pacemaker H-type currents, thus mak-
ing pyramidal cells more sensitive to post-inhibitory rebound
(Klaassen et al., 2006). (2) Alternatively, nAChR activation could
stimulate reciprocal inhibition between GABAergic interneurons,
thus producing pyramidal cell disinhibition (Figure 1). This latter
mechanism has been excluded in Klaassen’s work (2006), but may
explain Zhu’s results (2008). (3) Another possible mechanism
considers thalamocortical interplay. In stage 2 of sleep, spindle
waves are generated in the thalamus by the regulatory action of RT
cells onto thalamocortical cells (Lüthi, 2014), but cortical neurons
are essential in synchronizing their appearance in wide thalamo-
cortical regions. Sleep spindles can turn into epileptiform activity
and could be promoted by nAChR-dependent stimulation of glu-
tamate release onto RT cells and the release of GABA from RT
cells onto thalamocortical cells (Sutor and Zolles, 2001).
A more detailed interpretation is made difficult because of
the current uncertainties about the GABAergic cell populations
and their physiological roles in the neocortex. The classification
of GABAergic interneurons must take into account a number of
factors, such as morphology, axonal and dendritic connectivity,
efficacy and dynamics of input and output synapses, intrin-
sic electrophysiological properties, combinations of molecular
FIGURE 1 | Regulation by heteromeric nAChRs of a simplified layer V
neocortical microcircuit. Heteromeric β2∗ nAChRs regulate excitatory
transmission by stimulating glutamate release from thalamocortical as well
as intrinsic glutamatergic terminals. Expression of nAChRs on pyramidal
cell somata has also been observed, although it is more variable.
Heteromeric nAChRs also control GABA release onto pyramidal neurons.
Moreover, growing evidence indicates that nAChRs are also expressed in
several distinct types of GABAergic cells. However, because their precise
physiological roles in the different cell types is unclear, a comprehensive
picture cannot be given yet. This uncertainty is indicated by the question
marks in the graph. For full discussion and references, see the main text.
markers, such as Ca2+-binding proteins and neuropeptides, and
developmental origin (Markram et al., 2004; DeFelipe et al., 2013;
Cauli et al., 2014). The role of different GABAergic popula-
tions in the cortical microcircuit is unclear, and differences occur
between layers, brain areas and species. A simplified classification
(Figure 1), which covers more than 85% of cortical interneu-
rons, is based on expression of parvalbumin (PV), somatostatin
(SOM) and vasoactive intestinal peptide (Rudy et al., 2011;
Kepecs and Fishell, 2014; VIP). PV neurons are generally fast-
spiking (FS) cells (Hu et al., 2014), which are thought to be the
main responsible of surround inhibition, particularly in layer V.
Models of interactions between the GABAergic populations were
proposed based on studies on hippocampus and sensory, but not
associative, cortices (Pfeffer et al., 2013). While PV-cells mainly
inhibit the perisomatic compartments of pyramidal cells, SOM-
cells form synapses onto dendrites of pyramidal neurons and
inhibit PV interneurons (but not vice versa). SOM-cells would
thus not only increase inhibition in the dendrites but also decrease
the perisomatic inhibition mediated by PV-cells (Pfeffer et al.,
2013). In contrast, VIP-cells produce scarce inhibition of pyra-
midal cells, but seem to specifically target SOM-cells. In this
way, VIP-cells may indirectly stimulate PV-cells. This simpli-
fied picture is complicated by the presence of chandelier cells, a
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subtype of PV-cells that mainly targets the axon hillock of pyra-
midal cells. Their function seems critical in PFC (Hardwick et al.,
2005) and shows species-specific characteristics possibly related
to neurologic disorders (Woodruff and Yuste, 2008).
The study of how nAChRs regulate GABAergic populations is
in its infancy (Figure 1). Nonetheless, the non-FS cells (mainly
SOM, probably) that form GABAergic synapses onto FS-PV cells
(Harris and Mrsic-Flogel, 2013; Pfeffer et al., 2013) express α7,
α4, and β2 nAChR subunits (Freund, 2003; Couey et al., 2007;
Armstrong and Soltesz, 2012). Therefore, mechanism (2) above
could be facilitated in SWS, when glutamatergic transmission
weakens. In these conditions, inhibition between interneurons
may prevail because of nicotinic excitation of the cell bodies
of the non-FS cells that innervate the FS-PV-cells. Moreover,
FS-cells also present reciprocal inhibitory connections (Gibson
et al., 1999; Galarreta and Hestrin, 2002). Because FS-cell ter-
minals express α4β2 nAChRs, it is possible that when the over-
all glutamatergic input decreases, the action of hyperfunctional
nAChRs on presynaptic terminals shifts the synaptic balance
toward interneuronal inhibition.
WHY DO SEIZURES ARISE IN THE FRONTAL REGIONS?
Besides the local mechanism by which ADNFLE mutations can
alter the excitability of neocortical circuits, one must also explain
why seizures arise in frontal regions. Although the literature on
cholinergic transmission is immense, the analysis of the differ-
ences in cholinergic and, in particular, nicotinic regulation of
different areas of the isocortex is rather neglected. Interestingly,
recent results suggest that important differences exist in choliner-
gic innervation and response to nicotine between distinct regions
of the cerebral cortex. Inmouse, for instance, the response of layer
VI pyramidal neurons to nicotine in the medial PFC is more sen-
sitive than the one observed in primary somatosensory andmotor
cortices (Tian et al., 2014). This appears to be consistent with the
distribution of cholinergic fibers in infragranular layers, which
is denser in PFC, as compared to primary sensory and motor
regions (Aracri et al., 2010). Differences in cytoarchitectonics and
physiology are also observed between different prefrontal regions
(for a brief discussion, see Aracri et al., 2013a).
Moreover, a typical feature of ADNFLE is the presence of
stereotyped motor events accompanying the seizures, suggesting
that motor patterns are released during the attacks. Therefore, we
hypothesize that the implication of premotor areas such as Fr2
(also known as M2; discussed in Aracri et al., 2013a) is particu-
larly relevant for ADNFLE. This area projects to the motor cortex
and dorsolateral striatum (Berendse et al., 1992; Condé et al.,
1995). Moreover, it is very sensitive to nicotinic stimulation in
layer V (Aracri et al., 2010, 2013a), and its well-developed layer
V is seemingly accompanied by lesser inhibitory weight than is
typical in regions such as the somatosensory cortex (Aracri et al.,
2013a).
DEVELOPMENTAL ASPECTS
The subtle prefrontal circuit alterations that cause ADNFLE
seizures are likely to be produced during the developmental
phases of network stabilization, as is also indicated by conditional
expression of β2-V287L (Manfredi et al., 2009). In mammals, a
“brain growth spurt” occurs around birth, characterized by neu-
rite outgrowth, synaptogenesis, myelinization and circuit pruning
(Eriksson et al., 2000). In rodents, this phase spans the first
3, 4 postnatal weeks and is accompanied by maturation of the
cholinergic system and an upsurge of nAChR expression. In rat
forebrain, β2 appears in mid-gestation and peaks in the second
postnatal week, along with α4 and α7 (Mansvelder and Role,
2006). A similar pattern is observed inmouse (Kassam et al., 2008;
Bailey et al., 2012), although evidence is less extensive. At this
stage, the density of extrinsic cholinergic innervation (Mechawar
et al., 2002) and cortical cholinergic cells (Consonni et al., 2009)
increases dramatically. Treatment with nicotinic ligands in the
second postnatal week produces persistent behavioral and mor-
phological alterations (Eriksson et al., 2000) and mice lacking
β2 show region-specific changes in cortical structure (Cordero-
Erausquin et al., 2000). Nonetheless, the specific nAChR roles
during neural circuit wiring are still largely unknown. The spon-
taneous nAChR activity was reported to regulate the developmen-
tal switch between the excitatory and inhibitory roles of GABA
(Liu et al., 2006). The latter transition depends on the pro-
gressive substitution of the transporter NKCC1, which absorbs
Cl− and is mainly expressed in early stages, with KCC2, which
extrudes Cl− and is expressed at later stages (Rivera et al., 1999;
Ben-Ari et al., 2012). Both homo- and heteromeric nAChR activ-
ity seem to regulate expression of these transporters (Liu et al.,
2006). In particular, KCC2 appears after postnatal day 3 in layer
V pyramidal neurons. Its expression accompanies the formation
of GABAergic synapses and KCC2 variants have been associated
to epilepsy (Kaila et al., 2014; Puskarjov et al., 2014). Precise
timing of early GABAergic excitation is important for early neu-
ronal development and integration into circuits (Ge et al., 2006;
Ben-Ari et al., 2012). Recent work in transgenic rats expressing
α4-S284L (Zhu et al., 2008) suggest that this mechanismmay also
be active at a later stage. In these mice, the onset of the epilep-
tic seizures (around 8 weeks after birth) is accompanied by a
decrease of the expression ratio of KCC2 and NKCC1, with a con-
sequent depolarizing shift of the GABAA reversal potential, which
could explain the observed alterations in GABAergic transmission
(Yamada et al., 2013).
PHARMACOLOGICAL TREATMENT OF ADNFLE
A first-line choice for treating ADNFLE is carbamazepine (CBZ).
As many other antiepileptics (AEDs), CBZ has inhibitory effects
on voltage-gated Na+ channels (McLean and Macdonald, 1986).
Nonetheless, CBZ has been proposed to be particularly effective
on ADNFLE because it also blocks heteromeric nAChRs at thera-
peutic doses, and ADNFLEmutations alter the channel sensitivity
to the drug (Picard et al., 1999; Hoda et al., 2009). However, CBZ
can cause serious toxic side-effects produced by its metabolites. A
related less toxic second generation compound is oxcarbazepine
(Beydoun et al., 2008), which has recently found to give good
results in ADNFLE patients, including some refractory to other
drugs (Raju et al., 2007; Romigi et al., 2008). The steady-state
plasma concentration of oxcarbazepine is negligible and the clin-
ically relevant compound is thought to be the monohydroxy
derivative MHD, which can reach effective plasma levels between
30 and 150μM (Johannessen et al., 2003). In agreement with
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the notion that good efficacy in treating ADNFLE may depend
on modulation of nAChRs, oxcarbazepine and MHD can also
inhibit heteromeric nAChRs, especially α4β2 (Di Resta et al.,
2010). Lamotrigine, another AED commonly used in partial
epilepsy (Labiner et al., 2009), has also been found to block α4β2
nAChRs (Zheng et al., 2010). Unfortunately, the effects of com-
mon AEDs on ligand-gated ion channels have begun to be studied
only recently (Di Resta and Becchetti, 2013). Deeper analyses
on the action of AEDs on different ion channels and the search
of more specific compounds are clearly needed to advance the
pharmacology of ADNFLE and epilepsy in general.
Considering that many ADNFLE mutations produce an over-
all increase of receptor’s function and that several AEDs block
nAChRs, it may seem paradoxical that treatment with nicotine
has also been suggested to be beneficial in ADNFLE. After the
first report in a patient refractory to standard antiepileptic ther-
apy (Willoughby et al., 2003), the effect of tobacco habit was
studied in a wider cohort of patients carrying either α4-776ins3
or α4-S248F (Brodtkorb and Picard, 2006). Seizure freedom was
associated with smoking habits and transdermal nicotine applica-
tion had beneficial effects in one patient (Brodtkorb and Picard,
2006). The possible explanations of these observations are as
follows. First, tonic nicotine administration tends to produce
partial nAChR desensitization, which may counteract the effects
of receptors’ hyperfunctionality. Second, nicotine can act as a
molecular chaperon that regulates the nAChR subunit expression
(Kuryatov et al., 2005). In several ADNFLE mutations studied
in vitro, tonic nicotine application was observed to decrease the
overexpression of the high-affinity (α4)2(β2)3 subtype (Son et al.,
2009). Therefore, in ADNFLE patients, nicotine may normalize
an altered subunit stoichiomentry.
Investigating the pathogenesis and pharmacology of epilepsy
is complicated by the scarcity of good in vitro models, as it
is difficult to obtain spontaneous epileptiform activity in cul-
tured neuronal networks or brain slices. In the case of ADNFLE,
long-term neuronal cultures dissociated frommice expressing β2-
V287L display spontaneous hyperexcitability features (i.e., not
requiring the application of pro-convulsants), as measured with
multi-electrode arrays (Gullo et al., 2014). The network excitabil-
ity can be modulated by both GABAergic drugs and CBZ. Besides
facilitating the study of the role of β2-V287L on synaptic forma-
tion, this experimental model allows to determine the effects of
tonic pharmacological treatment on network excitability. In gen-
eral, in vitromodels such as this one should considerably facilitate
the screening of antiepileptic drugs (AEDs).
OTHER GENES IMPLICATED IN ADNFLE
KCNT1
Four missense mutations in the KCNT1 gene (Table 1), coding
for a Na+-gated K+ channel (KCNT1 or KCa4.1, also known as
Slo2.2 or Slack), were associated to severe ADNFLE with psy-
chiatric symptoms, and a penetrance of 100% (Heron et al.,
2012). Consistently, KCNT1 is expressed in the frontal region
(Bhattacharjee et al., 2002). The ADNFLE mutations tend to
cluster around the cytoplasmic NAD+ binding domain (Heron
et al., 2012), which regulates the channel sensitivity to [Na+]i
(Tamsett et al., 2009). When expressed in Xenopus laevis oocytes,
these mutations produce higher currents than the WT coun-
terparts. In analogy with what was discussed for the mutant
nAChRs, the balance of the possible physiological effects on exci-
tatory and inhibitory transmission is uncertain. It is possible that
hyperfunctional KCNT1 channels accelerate the action potential
repolarization, thus increases the firing frequency of pyramidal
neurons (Milligan et al., 2014). Because KCNT1 is also expressed
in interneurons (Bhattacharjee et al., 2002) it has been also sug-
gested that the slow accumulation of Na+ in FS interneurons
could stimulate KCNT1 to dampen excitability. The effect would
be stronger in the case of mutant channels, with ensuing network
disinhibition (Milligan et al., 2014).
DEPD5
Loss-of-function mutations in DEPDC5 are linked to different
types of focal epilepsies, including ADNFLE (Dibbens et al., 2013;
Ishida et al., 2013; Lal et al., 2014; Picard et al., 2014; Scheffer
et al., 2014). Differently from themutations on ion channel genes,
the epileptogenic mutations in DEPDC5 are unrelated to the spe-
cific area of seizure initiation. Therefore, DEPDC5 appears to
be implicated in overall excitability, rather than being specifi-
cally associated with ADNFLE. The DEPDC protein participates
in a molecular complex implicated in repressing the activity of
mTORC1 (Target Of Rapamycin Complex 1; Bar-Peled et al.,
2013). However, how the mTORC1 pathway may be linked to
epileptogenesis is unknown (Baulac, 2014).
THE POSSIBLE INVOLVEMENT OF NEUROPEPTIDES
Putative disease-causing mutations have been identified in the
promoter (Combi et al., 2005) or in the pro-sequence region
of CRH (Combi et al., 2005; Sansoni et al., 2013). In vitro, the
P30R substitution in the pro-sequence of CRH decreases peptide
secretion (Sansoni et al., 2013). How suppressed CRH signaling
may lead to ADNFLE seizures is unclear. Among neuropep-
tides, CRH is known to exert the most potent pro-epileptogenic
effects during development (Baram and Hatalski, 1998). The
hypothalamic neurons secreting CRH also innervate the neo-
cortex, and CRH receptors are densely distributed in rodents’
prefrontal regions (Radulovic et al., 1998; Van Pett et al., 2000),
thus cooperating with the ascending arousal systems, including
the cholinergic, particularly during the stress response. The other
hypothalamic neuropeptide implicated in neocortex arousal and
sleep-wake cycle is orexin (also known as hypocretin). Orexin
peptides directly regulate synaptic transmission in the frontal cor-
tex (Li et al., 2010; Aracri et al., 2013b), and cooperate with
ACh in modulating glutamate release from thalamocortical fibers
(Lambe et al., 2005). Until now no ADNFLE-linked mutations
have been observed on orexin-related genes (Bouchardy et al.,
2011). Nonetheless, we believe that the interplay between ACh,
orexin and CRH in regulation nurotransmission in the cerebral
cortex may be another fruitful line of research with implications
for sleep-related epilepsy in general and ADNFLE in particular.
CONCLUSIONS
Several genes have been associated with ADNFLE, but the avail-
able functional studies mostly concern heteromeric nAChRs.
Murine models suggest that alteration in the nicotinic control
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of GABAergic transmission may be a major pathogenetic mecha-
nism. In general, the prefrontal regions may be particularly sen-
sitive to nicotinic stimulation in the deep layers. However, a full
comprehension of epileptogenesis in ADNFLE will require a bet-
ter understanding of how the different nAChR subtypes regulate
both excitatory and inhibitory neurons, at pre- and postsynaptic
level, in the frontal regions. In particular, how nAChRs control
different interneuronal populations is unclear. Moreover, assess-
ing how the altered excitability is generated during thematuration
of neocortical connections will need deeper studies of the nAChR
function in the early postnatal weeks. From a pharmacological
standpoint, mounting evidence indicates that several classic AEDs
can target neurotransmitter-gated ion channels, and particularly
nAChRs. Modulating nAChRs is a possible therapeutic strategy in
ADNFLE, which merits further investigation.
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